1 Aug 2018 12:05
1 August 2018
FastForward Innovations Ltd
("FastForward" or the "Company")
Response to Media Speculation
FastForward notes the recent media speculation regarding the Company undertaking an equity fundraising in the short term.
Following the announcements of 19 July and 23 July 2018, the Company has options in place to subscribe for additional interests in Intensity Therapeutics Inc. ("Intensity") and Factom, Inc. ("Factom") and is therefore currently in discussions with investors concerning a potential fundraising to raise up to £5million. It expects to conclude this shortly and a further announcement will be made in due course as and when appropriate.
**ENDS**
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.
For further information on the Company please visit www.fstfwd.co or contact:
FastForward Innovations Limited info@fstfwd.co Sue Saunders / Ian Burns
|
Beaumont Cornish Limited (Nomad) James Biddle / Roland Cornish Tel: +44 207 628 3396
|
Optiva Securities Limited (Broker) Graham Dickson Tel: +44 (0) 203 137 1902
|
CAUTIONARY STATEMENT
The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.